News

The Promise and Pitfalls of Clinical Trials Overseas

See allHide authors and affiliations

Science  10 Oct 2008:
Vol. 322, Issue 5899, pp. 214-216
DOI: 10.1126/science.322.5899.214

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Big pharma has big incentives, including cost savings and more powerful studies, to launch trials in developing countries. But can companies avoid the ethical potholes?